BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10097910)

  • 1. Long-acting insulin analogs.
    Rosskamp RH; Park G
    Diabetes Care; 1999 Mar; 22 Suppl 2():B109-13. PubMed ID: 10097910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-acting insulin analogs: progressing slowly].
    Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1668-9. PubMed ID: 15453117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era.
    Bolli GB; Andreoli AM; Lucidi P
    Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S43-52. PubMed ID: 21668336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin analogues: place of detemir (levemir)].
    Dorchy H; Sternon J
    Rev Med Brux; 2006; 27(2):89-94. PubMed ID: 16736846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical strategies for controlling peaks and valleys: type 1 diabetes.
    Bolli GB
    Int J Clin Pract Suppl; 2002 Jul; (129):65-74. PubMed ID: 12166610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin analogues: place of detemir (Levemir)].
    Dorchy H; Sternon J
    J Pharm Belg; 2006; 61(2):58-62. PubMed ID: 16866083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin therapy].
    Brunetti P
    Minerva Endocrinol; 2001 Jun; 26(2):65-86. PubMed ID: 11479436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin detemir: a new basal insulin analogue.
    Soran H; Younis N
    Diabetes Obes Metab; 2006 Jan; 8(1):26-30. PubMed ID: 16367879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin glargine (Lantus).
    Owens DR; Griffiths S
    Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
    Bolli GB
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin preparations with prolonged effect.
    Owens DR
    Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S5-14. PubMed ID: 21668337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational use of insulin analogues in the treatment of type 1 diabetes mellitus.
    Bolli GB
    Pediatr Endocrinol Rev; 2003 Sep; 1(1):9-21. PubMed ID: 16437009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin therapy in type 2 diabetes: role of the long-acting insulin glargine analogue.
    Yki-Järvinen H
    Eur J Clin Invest; 2004 Jun; 34(6):410-6. PubMed ID: 15200492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.
    Robertson KJ; Schoenle E; Gucev Z; Mordhorst L; Gall MA; Ludvigsson J
    Diabet Med; 2007 Jan; 24(1):27-34. PubMed ID: 17227321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered insulin analogs: diabetes in the new millenium.
    Vajo Z; Duckworth WC
    Pharmacol Rev; 2000 Mar; 52(1):1-9. PubMed ID: 10699152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-acting insulin analogs: progressing slowly].
    Geelhoed-Duijvestijn PH
    Ned Tijdschr Geneeskd; 2004 Nov; 148(45):2248; author reply 2248-9. PubMed ID: 15568634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.